Davangere Sugar Company has agreed to convert loans into equity shares or convertible warrants, marking a significant development in the company's capital restructuring efforts. The company had earlier scheduled a Board of Directors meeting on July 28, 2026, to consider a proposal for raising funds through convertible warrants and/or other eligible securities via private placement, preferential issue, or other permissible modes.

Board Decision and Capital Restructuring

The fund-raising proposal was being considered pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issuance is to be conducted in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013, along with applicable rules.

Key Details

Approvals and Compliance

The fund-raising and conversion exercise remains subject to necessary statutory, regulatory, and other approvals. The transaction also requires the approval of the shareholders of Davangere Sugar Company. The Board retains the option to execute the issuance in one or more tranches, depending on market conditions and capital needs.

S. S. Ganesh, Managing Director of Davangere Sugar Company, signed the intimation letter dispatched to the stock exchanges on July 23, 2026. The company is listed on both the Bombay Stock Exchange and the National Stock Exchange of India Limited.

Davangere Sugar Company Limited has sanctioned a USD 84.95 million investment in its wholly owned foreign subsidiary, Aurevant Global Limited, marking a strategic expansion into the United Kingdom market. The Board of Directors approved the capital injection on July 25, 2026, utilizing proceeds from recently allotted Unsecured Foreign Currency Convertible Bonds (FCCBs). This move enables Davangere Sugar Company Limited to establish a dedicated operational entity in London focused on ethanol and sugar products, leveraging international currency instruments to fund overseas growth.

The investment aligns with the utilization plan outlined in the FCCB offering circular dated July 03, 2026. The FCCB issue, authorized by shareholders via a special resolution at the Extra-Ordinary General Meeting held on April 24, 2026, received in-principle approval from BSE Limited and National Stock Exchange of India Limited on June 10, 2026. The board finalized the allotment of these bonds on July 09, 2026. The current transaction is disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, adhering to SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Transaction Details

The capital injection involves cash consideration for the acquisition of new equity in Aurevant Global Limited. At an applied exchange rate of 1.36 GBP per USD, the USD 84.95 million investment is equivalent to approximately GBP 62.46 million. In return, Davangere Sugar will be allotted approximately 62,463,235 new Ordinary shares of GBP 1.00 each. Aurevant Global Limited, incorporated on June 04, 2026, under the Companies Act 2006, remains a wholly owned subsidiary with no prior turnover as it has yet to commence business operations.

Regulatory and Operational Framework

The investment is being undertaken under the Automatic Route in terms of the applicable provisions of the Foreign Exchange Management Act, 1999, requiring no prior governmental approval at this stage. However, the company noted that it will obtain any subsequent approvals if required by changing regulatory circumstances. The indicative timeline for completing the necessary procedures under the Overseas Direct Investment framework is within 10 days. Since Aurevant Global Limited is an existing wholly owned subsidiary, the transaction does not constitute a related-party transaction involving external promoters or group companies outside the consolidated structure.

What the Numbers Show

The immediate deployment of nearly 85% of the maximum permissible FCCB proceeds (USD 100 million) into a single newly incorporated entity highlights a concentrated strategic bet on the UK market. By channeling funds directly into Aurevant Global Limited, which operates in the same line of business as the parent company, Davangere Sugar aims to replicate its domestic success in ethanol and sugar products internationally. The use of a fixed exchange rate of 1.36 GBP per USD for this valuation provides clarity on the capital base established in London, shielding the initial accounting entry from immediate currency volatility while setting a clear benchmark for future performance evaluation in the region.